Delivery Order SPE2DB22D1106-SPE2DB24FEZG0

Award Date 6/27/24
Potential Completion Date 7/19/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,491.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of February 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ03N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,121.56 Firm Fixed Price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency Troop Support Medical awarded a $12,042.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg tablets of LUMAKRAS in 240 count bottles. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support DLA Troop Support Medical programs. No major subcontractors or set aside designations were identified. This delivery order was issued on the agency's...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,177.78 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Lacosamide 10 mg/ml solution in 200ml bottles. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $25,129.86. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
The U.S. Defense Logistics Agency (DLA) awarded a $12,994.39 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of pharmaceutical products and medical supplies. This contract, with a completion date of September 24, 2024, is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, will provide a range of prescription medications, over-the-counter drugs, and medical commodities to support military treatment facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $2,740.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of pharmaceutical and medical products. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of medications, medical devices, and supplies to DLA...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,590.30 delivery order contract to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to federal agencies. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of medical commodities, including specialty, brand name, generic,...
The U.S. Defense Logistics Agency (DLA) awarded a $5,950.50 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of medications and medical supplies...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $19,198.52 firm fixed price delivery order contract to supply 60 tablets of the medication LONSURF 20 MG-8.19 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp, which serves as the prime contractor for providing pharmaceuticals and medical supplies to DLA Troop Support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEZG0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $25,121.56 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting AmerisourceBergen's competitive position in the federal pharmaceutical supply market. As a major supplier of medical products to the U.S. government, AmerisourceBergen leverages its extensive supply chain network to efficiently fulfill these critical government requirements.

Generated 9/26/24, 9:38 AM